Dr. George Bartzokis, a neuroscientist who originated the theory that the degeneration of the brain’s myelin contributed to many developmental and degenerative diseases, such as schizophrenia and Alzheimer's, died of pancreatic cancer on August 22. He was 58.
On Friday, August 15, 2014, Enoch Callaway III or "Noch" as his many friends and colleagues called him, passed away peacefully with his family present at his tranquil hilltop home in Tiburon California. Noch was a Founding Member of the ACNP and so much more.
John C. Craig, an Emeritus Professor of Chemistry and Pharmaceutical Chemistry at the University of California, San Francisco, died suddenly on Sept. 26th of complications related to cardiac disease.
Peter B. Dews (1922–2012) passed away November 2 in the Brigham and Women’s Hospital a few steps from Harvard Medical School where he spent the majority of his career and where his intellectual and research efforts shaped the way in which the behavioral effects of drugs are studied.
Svein Dahl, Professor and Chair of Pharmacology at the University of Tromsø, and an ACNP Fellow, succumbed to cancer on December 8th, 2012. He died at his home near Tromsø, Norway, the city where he was born in 1942.
Described as “a technological wizard”, Jose Delgado, invented the “stimoceiver”; implanted electrodes which established two way communications with the brain in mobile animals allowing Jose to stimulate different regions, producing changes in affect and behavior.
Obituaries in the major newspapers reported Joseph Vincent Brady, Ph.D. as the researcher who sent trained monkeys and chimpanzees into orbit to prove that outer space was safe for astronauts.
Dr. Alan Arthur Boulton was a pioneer in quantitative research on trace amines including 2-phenylethylamine, tyramine, octopamine and tryptamine, and their involvement in the etiology and pharmacotherapy of psychiatric and neurologic disorders.
Dr. Seymour (Sy) Antelman was internationally known for the originality and importance of his work on biological effects of stress and the effects of psychotropic drugs on the brain and behavior.
Thomas P. Detre was a renowned psychiatrist, academic leader, health care visionary and a long-term member of the ACNP. His creative approaches provided a model for the treatment of mental and addictive disorders to move closer to that in other domains of medicine.
In 1953 Dr. Ayd became the first clinician in the
United States authorized by the FDA to study chlorpromazine
in patients. In 1955 he published the results,
initiating the modern era of psychopharmacology
in this country.
Henri Begleiter, Ph.D., was a leader in the fields of neuroscience, alcoholism and genetics. Dr. Beigleiter was instrumental in organizing the largest study in the world focused on the genetics of alcoholism.
Wagner H. Bridger, M.D., published over 100 papers, was a founding member of the Society of Biological Psychiatry and President of the Society in 1988 and Editor of the journal from 1992-1997.
John J. Burns, Ph.D., supported basic science research more than any other pharmaceutical executive, both within his company as well as in the academic community. One of his most outstanding contributions was the establishment of the Roche Institute of Molecular Biology.
C. Jelleff Carr Ph.D., a founding father of the International Society of Regulatory Toxicology and Pharmacology, died on February 15, 2005.
Dr. Cole, a founder and early ACNP president,
received the first Paul Hoch Distinguished Service
Award. As CINP secretary, 1965-1969, his
contributions were recognized with the coveted
Pioneers in Psychopharmacology award.
Dr. Costa's enthusiasm and ability to
translate scientific hypotheses into successful
experiments were contagious for
all his collaborators—more than 300 in
Samuel Eiduson, Ph.D., one of neurochemistry's early pioneers, was the prime mover of the four authors of 'Biochemistry and Behaviour', which became the first major text for many subsequent investigators.